Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/QMH.0000000000000324 http://scihub22266oqcxt.onion/10.1097/QMH.0000000000000324 34048378!8462300!34048378     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34048378&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Qual+Manag+Health+Care 2021 ; 30 (4): 276-279 Nephropedia Template TP {{tp|p=34048378|t=2021. A Rapid Guidance Process for the Development of an Anticoagulation Protocol in the COVID-19 Pandemic |pdf=|usr=}}{{34048378}} gab.com Text A Rapid Guidance Process for the Development of an Anticoagulation Protocol in the COVID-19 Pandemic JO: Qual Manag Health Care http://www.kidney.de/pget.php?&tw=1&pmid=34048378 #FOAvip Health care systems have encountered unprecedented challenges during the coronavirus disease-2019 (COVID-19) pandemic, such as standardizing care in the absence of high-quality data. As an emblematic example, preliminary data and early anecdotal experience suggested that a major driver of COVID-19 pathophysiology was hypercoagulability, suggesting the need for aggressive anticoagulation. In this article, we describe the rapid guidance process for the development of an anticoagulation protocol for COVID-19. Preliminary evidence was collected from multidisciplinary experts within our institution to inform the first protocol draft. After implementation, we rapidly acquired data to inform a revision, with subsequent modifications based on higher quality data. The description of this process can inform other health systems when faced with a similar crisis characterized by high patient volumes, poor clinical outcomes, lack of proven effective therapies, and rapid flow of information from multiple sources of variable credibility. Twit Text FOAVip A Rapid Guidance Process for the Development of an Anticoagulation Protocol in the COVID-19 Pandemic ????Qual Manag Health Care http://www.kidney.de/pget.php?&tw=1&pmid=34048378 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34048378 #FOAvip English Wikipedia <ref>{{Cite pmid|34048378}}</ref> A Rapid Guidance Process for the Development of an Anticoagulation Protocol in the COVID-19 Pandemic #MMPMID34048378 Tremblay D; Dunn AS; Oh WK Qual Manag Health Care 2021[Oct]; 30 (4): 276-279 PMID34048378show ga Health care systems have encountered unprecedented challenges during the coronavirus disease-2019 (COVID-19) pandemic, such as standardizing care in the absence of high-quality data. As an emblematic example, preliminary data and early anecdotal experience suggested that a major driver of COVID-19 pathophysiology was hypercoagulability, suggesting the need for aggressive anticoagulation. In this article, we describe the rapid guidance process for the development of an anticoagulation protocol for COVID-19. Preliminary evidence was collected from multidisciplinary experts within our institution to inform the first protocol draft. After implementation, we rapidly acquired data to inform a revision, with subsequent modifications based on higher quality data. The description of this process can inform other health systems when faced with a similar crisis characterized by high patient volumes, poor clinical outcomes, lack of proven effective therapies, and rapid flow of information from multiple sources of variable credibility. |*COVID-19 Drug Treatment[MESH] |*Clinical Protocols[MESH] |Anticoagulants/*administration & dosage[MESH] |Humans[MESH] |Pandemics[MESH] |SARS-CoV-2[MESH]A Rapid Guidance Process for the Development of an Anticoagulation Pro(epmc).pdf DeepDyve Pubget Overpricing